Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 14,629 shares at $420.79 ($6.2M) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Scheduled sale ($6.2M) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $424.01 | 3,498 | $1.5M | 24.1% |
| 2 | $420.58 | 2,623 | $1.1M | 17.9% |
| 3 | $420.79 | 4,254 | $1.8M | 29.0% |
| 4 | $420.79 | 4,254 | $1.8M | 29.0% |
| Total | $421.52 avg | 14,629 | $6.2M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |